Ruifan® Pulmonary Artery Thrombectomy Stent System

Shanghai, China

Founded in 2021,EverBridge Group is a global diversified medicaltechnology company focusing on high clinical need chronic diseases. Ourmission is Bridging Medtech Innovations from Asia to the World . Adhering to the core philosophy of rapid and high quality scaling ,EverBridge Group has successfully built an enabling platform thataccurately captures global industry trends and market demand to servecustomers globally. By leveraging the strong R D capability of our state-of-the-art MedicalTechnology Research Institute,and the technical and manufacturingcapability of our Six Technology Centers ,we have successfully executed onour innovative product roadmap.With the support of our unique The EBS(EverBridge Business System) ,a lean management approach,we have alsorapidly scaled our business.In the global medical device market,EverBridgeGroup has won wide recognition and praise from customers globally for itscomprehensive product portfolio,excellent product quality,efficientproduction capacity,and strong marketing and sales network. EverBridge Group is dedicated to building a bridge fo medical technologyinnovation by actively developing global connections and communication to accelerate the advancement of medical technology.By collaborating withmany outstanding global partners on better innovation and development ofmedical technology,we have provided cutting-edge,high-quality andaffordable medical technology for patients with high-incidence chronicdiseases around the world.We look forward to continuing to help patientsglobally achieve excellent treatment experiences and improved outcomes.